Klinisk virkning Forekomst af frakturer Det primære studie var et 18 måneders dobbelt- blindet og placebokontrolleret fase III studie (TOP), der skulle undersøge Preotacts effekt på forekomsten af frakturer hos postmenopausale kvinder med osteoporose.
Clinical efficacy Effect on fracture incidence The pivotal study was an 18-month double-blind, placebo-controlled, phase III study (TOP) of the effect of Preotact on fracture incidence in women with postmenopausal osteoporosis.